Keywords: interim, pretax, up, wellcome, profits, first, six
INTERIM PRETAX UP 12% AT WELLCOME
Article | 28 March 1994
Pretax profits for the first six months of fiscal 1994 ended February 28 advanced 12% to L64 million ($541.8 million) at the UK pharmaceutical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
